Test your feet

"Exciting Innovation"

 

Stella Vig, a consultant vascular and general surgeon and chairwoman of the London Diabetic Foot Network, says:

“This is an exciting innovation. In association with a yearly foot screen and referral to the podiatry services, this will reduce the risk of amputations.

Screening for "at-risk" feet
 

​Andrew J.M. Boulton:
The pathway to foot ulceration: Autonomic neuropathy leading to dry skin and callus build at such sites, and can be regarded as a component cause. Screening for „at-risk“ feet is the job of all of those caring for people with Diabetes. 

All diabetic patients with an abnormal neuropad® test had structural denervation of the feet

 

C. Quattrini et. al.

A comparative study of the neuropad®  test versus skin biopsies from thedorsum of the foot showed that all diabetic patients with abnormal neuropad® test had significantly lower IENFDs compared to diabetic patients with a normal neuropad® response and healthy subjects.

@2014 by TRIGOcare International GmbH

TRIGOcare International GmbH

In den Wiesen 3

51674 Wiehl

Germany

Looking for Distributers

info@trigocare.com

CALL

Tel:  +49 (0) 22 62 - 72 701-0

Fax: +49 (0) 22 62 - 72 701-10

 

  • Wix Facebook page
  • Wix Google+ page

 

 

IMPRESSUM